newsfilter
← Latest News
PR Newswire·

Phio Pharmaceuticals Announces Appointment of Robert Bitterman as Executive Chairman

MARLBOROUGH, Mass., Sept. 29, 2022 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™) therapeutic pl